Zymonic acid - a novel 13C enriched biosensor for in vivo pH-imaging
Christian Hundshammer1,2, Stephan Düwel1, Malte Gersch3, Benedikt Feuerecker1, Axel Haase4, Markus Schwaiger1, Steffen J. Glaser3, and Franz Schilling1

1Department of Nuclear Medicine, Klinikum rechts der Isar, München, Germany, 2Department of Chemistry, Technische Universität München, München, Germany, 3Department of Chemistry, Technische Universität München, Garching, Germany, 4Department of Medical Engineering, Technische Universität München, Garching, Germany

Synopsis

[1,5-13C2] Zymonic acid is derived from carbon 13 labelled pyruvic acid and can be easily deuterium enriched for spin lattice relaxation time prolongation. The molecule exhibits pH dependent NMR shifts and can be used for pH in vivo mapping. Phantom measurements on human blood on a 7T preclinical MRI system indicate that [1,5-13C2] ZA is a suitable pH sensor for pre-clinical and potentially also for clinical applications.

Introduction

The pH plays an important role in many diseases, such as cancer and inflammation1, 2. Various attempts have therefore been made to translate a reliable and non-invasive pH imaging technique into the clinic. Recently, magnetic resonance imaging based pH imaging methods using hyperpolarized molecules like bicarbonate3, Goods buffers4, and pyridine derivatives5 have shown great potential for pH imaging. However, none of these techniques has reached the clinical stage yet.

Here we present the spectroscopic characteristics of a new molecule for in vivo pH imaging, called zymonic acid (ZA). We measured the pH dependent chemical shift of all atoms and synthesized deuterium enriched [1,5-13C2]ZAd, [2,4-13C2]ZAd, and [3,6-13C2]ZAd to determine the spin lattice relaxation time (T1) of each individual hyperpolarized 13C atom. Blood phantom measurements with [1,5-13C2]ZAd on a pre-clinical 7T MRI system reveal a great potential of ZA for in vivo pH measurements.

Methods

13C-labelled ZA was synthesized in one step using commercially available 13C-labelled pyruvic acid and deuterium enriched solvents6. The purification was carried out on a C18 reversed phase HPLC (2% – 20% acetonitrile in water) and the product was freeze dried.

High field NMR spectra were recorded on a 600 MHz Bruker Avance spectrometer. 4 M ZA in DMSO were doped with 15 mM trityl radical (OX063) and 5 mM Dotarem and hyperpolarized in a HyperSense polarizer. The dissolution was performed in 0.1 g/L EDTA and an adequate amount of NaOD in D2O. T1 measurements were performed on solutions with a final concentration of 25 mM (50 mM for MRI experiments) on a SpinsolveCarbon benchtop NMR spectrometer (Magritek, B0=1T) using a 10 degree flip angle and a repetition time of 3 s. T1 decay curves were flip angle corrected and fitted by a mono-exponential decay curve.

Imaging experiments were performed on human blood, the pH adjusted with NaOH or HCl, on a 7T small animal scanner (Agilent/ GE) using chemical shift imaging with FOV=6cm, matrix size=16x16, TR =118ms, FA=3°.

Results and Discussion

Zymonic acid consists of six carbon atoms and bears a stable enol group with its pKa in the physiological range (pKa~7.0). Deprotonation of the hydroxyl proton changes the electron density of all neighboring carbon atoms. This leads to pH dependent chemical shift changes up to 3.0 ppm/ pH, which are fast on the NMR time scale (Fig. 1). Carbon atoms number one, two, three, and five exhibit changes in chemical shift values of ∆δ~1.5-3.0 ppm between pH 6.3-7.5. The resonance signals of C4 and C6 exhibit smaller chemical shift differences of ∆δ~0.7 ppm and ∆δ~0.5 ppm. Carbon 13 NMR spectra of hyperpolarized [1,5-13C2]ZA at several different pH values reveal the stability of the molecule throughout the dissolution process and its ability to report pH after hyperpolarization (Fig. 2).The T1 of the carbon atoms one and five is 53±3 s and 115±3 s, respectively (n=3). The T1 of carbon atoms two, three, four, and six is 30±1 s, 16 s, 51±1 s, and 13 s (n=3 and n=1).

Phantom measurements of [1,5-13C2]ZAd dissolved in human blood show that ZA is able to spatially resolve different pH values in a bodily fluid (Fig. 3). The pH values calculated by the chemical shift difference of ZAd correlate well with the values measured with a pH electrode after the imaging experiment.

Conclusion

High field NMR measurements demonstrate that zymonic acid bears four highly pH sensitive 13C atoms. Furthermore, we have shown that these atoms have a long T1 and that the molecule is not harmed by the dissolution process. As a first step for going from in vitro towards in vivo pH measurements, blood phantom measurements indicate that [1,5-13C2]ZA is a suitable pH sensor for pre-clinical and potentially also for clinical applications.

Acknowledgements

This work was funded by EU Grant No. 294582 (MUMI), BMBF (FKZ 13EZ1114), DFG (SFB 824).

References

[1] Schroeder, M. A. et al. (2008). PNAS. USA. 105, 12051-12056.

[2] Gillies, R. J. et al. (2004) IEEE EMBS 23, 57-64.

[3] Gallagher, F. A. et al. (2008). Nature 453, 940-943.

[4] Flavell, R. et al. Chem. Comm. (2015) 74, 14119-14121.

[5] Longo, D. L. et al. (2014) JACS. 136(41), 14333-14336.

[6] Wolff, L. Liebigs Ann. Chem. (1899). 305, 154-165.

Figures

Figure 1: (a) 13C labels (red) of zymonic acid when synthesized from [1-13C], [2-13C] or [3-13C]pyruvic acid. (b) Chemical shift differences at different pH values and T1 values of all six carbon atoms. The 13C NMR titration curves were acquired on a 600 MHz NMR spectrometer using fully carbon 13 labelled zymonic acid. The T1 values were obtained using [1,5-13C2]ZAd, [2,4-13C2]ZAd, and [3,6-13C2]ZAd.

Figure 2: (a) Stacked spectra of hyperpolarized [1,5-13C2]ZA at different pH. All spectra were referenced to the chemical shift of carbon atom one, which was set to zero. Note that both 13C atoms exhibit a pH dependent chemical shift. (b) pH dependent chemical shift difference of carbon atom one and five.

Figure 3: (a) pH map of human blood phantoms calculated by the chemical shift difference of [1,5-13C2]ZAd compared to the pH measured by a pH electrode (b).



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
3674